Trump Wants to Overhaul Drug Sales. a Company Tied to His Son Stands to Benefit
Posted3 months agoActive3 months ago
wsj.comOtherstory
skepticalnegative
Debate
10/100
Trump AdministrationPharmaceutical IndustryConflict of Interest
Key topics
Trump Administration
Pharmaceutical Industry
Conflict of Interest
The Trump administration is proposing changes to the pharmaceutical industry, which could benefit a company tied to Trump's son-in-law, raising concerns about potential conflicts of interest.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
20s
Peak period
1
0-1h
Avg / period
1
Key moments
- 01Story posted
Oct 8, 2025 at 5:36 AM EDT
3 months ago
Step 01 - 02First comment
Oct 8, 2025 at 5:36 AM EDT
20s after posting
Step 02 - 03Peak activity
1 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Oct 8, 2025 at 5:36 AM EDT
3 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
Discussion (1 comments)
Showing 1 comments
impish9208Author
3 months ago
Gift link: https://www.wsj.com/health/pharma/trumprx-drug-companies-bli...
View full discussion on Hacker News
ID: 45514068Type: storyLast synced: 11/17/2025, 11:09:49 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.